Sanofi Pasteur's India Arm Shantha Lands WHO Supply Contract For Pentavalent Vaccines
This article was originally published in The Pink Sheet Daily
The new contract reflects Sanofi-Aventis CEO Chris Viehbacher's plan of reaching out to newer populations through affordable treatments.
You may also be interested in...
MUMBAI - French drug maker Sanofi-Aventis sees Shantha Biotech - its latest Indian acquisition - as a hub to further its global biotech ambitions but may not rush to buy more companies in India
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.